Racial, Ethnic Differences ID'd for Idecabtagene Vicleucel in Multiple Myeloma

WEDNESDAY, Oct. 25, 2023-- There are some racial and ethnic differences in safety and response to standard of care (SOC) idecabtagene vicleucel (ide-cel) in patients with relapsed/refractory multiple myeloma (RRMM), according to a study published...